A Study Of Panobinostat In Children With Refractory Hematologic Malignancies

This study has been completed.
Sponsor:
Collaborator:
Novartis
Information provided by (Responsible Party):
Therapeutic Advances in Childhood Leukemia Consortium
ClinicalTrials.gov Identifier:
NCT01321346
First received: March 21, 2011
Last updated: November 20, 2015
Last verified: November 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: October 2015 (Final data collection date for primary outcome measure)